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ABSTRCAT:
The term transgenic animal refers to an animal whose genetic composition has been altered by an addition of foreign DNA. The introduced DNA is called a transgene and the overall process is called transgenic technology. These terms now include the use of living organisms or their parts to make or modify products, to change the characteristics of plants or animals, or to develop micro-organisms for specific uses that currently include several plants and a number of animal species. During the last two decades, transgenic animal model has been an essential mainstay tool in refining our understanding to gene regulation and function of both biological systems and human diseases. The aims of this review article are 1) to elaborate on how transgenic technology is being used to develop the next generation of animal models and 2) to provide an update of the recent advances and a possible structure design for future studies. This review covers the most used animal models of some human disease and specifically discusses two studies conducted on a mouse model of experimental autoimmune encephalomyelitis (EAE) that reproduced specific features of the histopathology and neurobiology of Multiple Sclerosis (MS). This report is presented with the hope to provide both educational and practical basis for the use of these informative animal models. , the first technique that proves to be a successful application in mammals. In addition it was the first technique introduced to mice and subsequently to other species such as rats, rabbits, sheep, pigs, birds, and fish 
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B. Retroviral vector approach.
Theaimis to increasethe probability of expression; gene transfer is mediated by means of a carrier or vector, usually a virus or a plasmid. Retroviruses are commonly used as vectors to transfer genetic material into the cell, taking advantage of their ability to infect host cells, the technique order as follow: -Embryos are infected with the retrovirus.
-The retrovirus mediates integration of the transgene into the host genome.
-The modified embryo is placed into the uterus of a surrogate mother. 
C. DNA Microinjection approach
Thistechnique includes the direct microinjection of a chosen gene construct (a single gene or a combination of genes) from another member of the same species or from a different species, into the pronucleus of a fertilized ovum, the technique order as follow: -Eggs are fertilized in vitro. -The transgene carried by a modified retrovirus is microinjected into the male pronucleus. -The transgene integrates into host chromosome.
-The zygote grows in culture to the blastocyst stage.
TRANSGENIC MICE AS MODELS FOR HUMAN DISEASE:
Animal models areessential part in medical researches that lead to more understanding of human disease processes and, subsequently, the testing of potential therapeutic strategies such as: A. Transgenicmouse modelsofAlzheimer's disease (AD) Transgenic mouse models of psychiatric disease. 13 The full scope of all transgenic models would be too varied to cover in one paper. As such only the 4 mentioned models will be covered in this publication.
A: Alzheimer's disease (AD) models:
AD is a progressive neurodegenerative disease. Majority of AD cases are sporadic; however few show a familial pattern, which might contribute into the disease's origin and mode of action. Transgenic mouse model have been thoroughly investigated the familial forms through overexpressing the mutated alleles of the familial Alzheimer's disease linked genes APP 9 , PSEN1 and PSEN2 49 . APP, PSEN1, and PSEN2 have over 100 rare and highly penetrant mutations that are implicated in early onset of AD. Alternate modeling studies show that apolipoprotein E associated with increased susceptibility to AD in later years 21 . Recent studies suggest that all mutations of these 4 critical AD linked proteins account for less than 30% of the genetic component to the disease; worth noting that Mouse models will be critical to the identification of other related genetic factors 20 .The first transgenicAlzheimer's disease models were used the amyloid precursor protein (APP) gene. The resultant APP23 model that first described by Sturchler-Pierrat and colleagues, is a highly valuable, and frequently cited, model of Alzheimer's disease research and neurodegenerative disease in general 9 . This transgenic mouse line was created by expressing APP751 containing common APP mutations found in Alzheimer's patients. The model suggests 4 new pieces of information: 1) early and late onset AD presentations are distinct from each other, indicating different causes or mechanisms. 2) Age of onset varies within the family.3) Only 1/3 of the theoretical predisposition to AD will become manifest during the lifetime of those at risk. 4) A single dominantgene with a popula-tion allele frequency of [0.13 is responsible for the increased susceptibility after the 9 th decade of life 9 . These findings represent how useful mouse models can be as a tools for the comparison of dissimilar disease states that may have multiple mechanisms of action. Since the original model in 1997, significant leaps have been made from simply observing the effectsof different mutations to actively trying to manage and treat the effects of AD. A recent study by Sung Ok Yoon and colleagues (2012) 21 found that, Alzheimer's mice expressing amyloid plaques that mimic aggressive forms of the AD patients, the elimination of amyloid peptide inducer jnk3 leads to a 90% reduction in the number of these plaque forming peptides. Further comparison of the brains of AD patients reveals that a 30-40% comparative increase in jnk3, suggesting jnk3 as a target in future AD treatment 22 .
B: Poliomyelitis models:
Poliovirus is a tropic to the nervous system; once the virus infects the nervous system it will cause[ [ a[ neurodegenerative disease called poliomyelitis. This disease is characterized by destruction of motor neurons and eventually leads to skeletal muscle paralysis. Mice are immune to polio infection because they lack the cell surface protein (polio receptor) to which the poliovirus binds 10 . Ruibao Ren and colleagues created a mouse model which could be infected by poliomyelitis by creating a transgenic mouse line that expressed the human polio receptor (PVR) gene 11 . This modified mouse used to generatea mouse model of poliovirus's neurovirulence, attenuation, and tissue tropism, in addition, because the PVR modified mice express the human cell receptor, human specific poliovirus vaccines can be tested in mice, allowing more improvement in vaccine efficiency 11 . The first transgenic mouse models for polio utilized the technique to search for the critical regions influencing infectivity in both the human-mouse receptor, and the genome of the virus itself 23 . Subsequent models, such as Shane Crotty and colleague's mouse model, examined the patterns of infection and severity of effects of poliovirus as well as aggravating factors for the disease from the mice themselves, such as age and method of infection 24 . Recent and likely future models will deal with the use of modified poliovirus and PVR modified mice in order to find therapeutic approaches towards treating tumors and nervous system trophic disorders 25 .
C: Osteoarthritis (OA) models:
OA is acomplex disease with many contributing factors. OA can result from traumatic insult, congenital or developmental disease, bone and joint diseases, insufficiency of cartilage properties, or neuropathic arthropathy. Due to the differences in animal cartilage, animal studies cannot be comparable to human tissue with any regularity, as even among humans OA occurs due to a variety of stresses and genetic factors. Animal models may be similar in phenotype, but with different underlying conditions contributing compared to human OA 26 . Transgenic mice, expressing genes associated with development of OA in humans, share more promise in creating relevant animal models in these scenarios 12 . Researchers investigatedthe use of the spontaneous mutations which occur naturally in several mouse strains to define regions of interest. Strains with mutations in cartilage collagen types II and IX develop early onset OA 27 .These non-transgenic mice make promising modelsof age related OA. Unfortunately, they often show signs of chondrodysplasia, experiencing abnormal bone growth where fibrous bone tissue replaces normal bone tissue 28 . Their heterogeneous offspring are more typical but still show the early-onset OA phenotype, making them useful for isolating defined mutations that act as predisposing factors to OA 12 . The OA phenotype has been linked to mutations affecting the different types of collagens, but the regulation and expression of type II, IX, and XI collagens in relation to OA is poorly understood 29 ; Transgenic animal models offer an opportunity for more in depth studies of these human collagen mutations. The human transgenes Col2a1, Col9a1, Col11a1 have high homology, and are indicated as being related to the regulation of CII, CIX, and CXI 29 . Deletions and substitutions of critical regions of Col2a1 in transgenic mice leads to phenotypes resembling chondrodysplasia 12 ; increasing expression rate of typical Col2a1 that lead to OA, as the fibril assembly of the collagen is disrupted from irregular expression 30 . Type IX collagens are heterodimers consisting of three polypeptide chains, which covalently bind to the surface of type II collagen and anchor them to the surrounding matrix. Truncation of these chains leads to mild chondrodysplasia, and progressive OA in mice. Young mice are phenotypically normal, but experience severe spinal degradation from 6 months of age and onward 31 . Disturbances in Col11a proteins related to XI collagen have variable effects on the susceptibility of mice to OA. Targeted disruption of Col11A2 does not cause the pronounced OA phenotype seen by disruption of Col11A1, but it does produce a milder effect after 1 year of age, implicating CXI disruption in late onset OA 32 .
D: Psychiatric disease models:
Genetic susceptibility to common psychiatric disease arises from the complex interactions between multitudes of genes; these diseases also have a strong environmental component. While it is unlikely that transgenic mice will show complex disorders such as schizophrenia, obsessive compulsive disorders, or autism due to their complex sociological and cultural components 13 . Mouse models can be extremely effective in separating the specific roles of genes, neural pathways, neuron subtypes, and brain regions in specific states of abnormal behaviour. Numerous mouse models of psychiatric disorders have already been generated 13 . Such models cover ranges of abnormal behaviour, such associal anxiety, unbalanced mood swings, psychomotor agitation, and learning/memory impairment 13 , 33, 34. Many well categorized psychiatric disorders such as Autism, Schizophrenia, mental depression, and Attention deficit hyperactivity disorder, while extremely complex and affected heavily by human cognition and culture, share physiological traits which can be used to approximate these disorders in animal models 13 .Neuroanatomy findings in schizophrenia are classic hallmarks of the disorder and manifestas larger brain volume/weight and decreased concentration of purkinje cells in the human cerebellum, this reduced cerebellar size also occurs in mice 35 . These intermediate traits can be used in transgenic animal studies to characterise genes which may be associated with phenotypes associated with mental illness. Following the previous theme of schizophrenia, experiments in transgenic mice carrying a gene known as disrupted-in-schizophrenia-1 (DISC1) 33 found that the mice have enlarged lateral ventricles on their left side of their brains, which suggests a link to the asymmetrical change in neuroanatomy found in human schizophrenia patients. Bipolar disorder is another mental disorder characterised by periods of mania or depression in individuals with otherwise normal moods 36 . The DSM classifies Bipolar disorder based on clinical presentation, Bipolar I characterized by the occurrence of one or more manic or mixed episodes and Bipolar II by at least one hypomanic or major depressive episode 37 . Considering both classes of the disease, the world prevalence of Bipolar disorder is about 3.5% 13 . Animal models are commonly utilized to investigate the effectiveness of lithium and other mood stabilizers and determine their mechanism of action 38 .
ASIDE:
Transgenic mouse research has led to major advances in the ability to treat a number of diseases. For example, work on mice resulted in successful therapies of acute promyelocytic leukaemia (APL) 14 , a cancer that was previously untreatable. Disease models such as the Alzheimer's Mouse, the Oncomouse, and the AIDs mouse are critical laboratory models for developing treatments for these specific diseases and cancer studies 15 .
TRANSGENIC MICE AS A MODELS OF MULTIPLESCLEROSIS DISEASE-EXAMPLES FROM OUR RESEARCH. 1) Multiple sclerosis -Study1
Axonal damage, demyelination and inflammation of the central nervous system are the major pathological features of the human multiple sclerosis (MS). In our experiment we used the Experimental autoimmune encephalomyelitis (EAE) animal model that mimics human MS and tested the effect of Thymoquinone (TQ) 16 , an oil constituent of Nigella Sativa also known as black seed. Thymoquinone (TQ) has shown advantageous immunomodulatory properties amplifying the T-cell immune responses 41, 40 . TQ, an oil extract from the seeds of Nigella Sativa, has many pharmacological and toxicological properties 39 . Studies have shown TQ to have anti-inflammatory, analgesic, antipyretic, antimicrobial,and anti-neoplastic activity 39, 43, 40, 30 female mice strain C57BL/6J of age between 6 to 12 weeks and weight between 20-22gms were divided into 3 groups 10 mice each. Group A, B and C, all received 100 μg MOG (SC) to induce EAE. Group A used as a control animal models of EAE for the acute and relapsing stages respectively. Acute phase ran for 28 days post EAE induction while the chronic phase ran for 50 days post EAE induction. Group B, received MOG (SC) and TQ (IP) from day 1 till day 50, while group C, received MOG (SC) and then TQ (IP) on the appearance of first sign and symptoms of CR-EAE. TQ was given for 5 consecutive days to treat the CR-EAE. Preliminary result showed that TQ, due to its antioxidant effect, is almost 90% preventive and 50% curative in CR-EAE 16 . 2) Multiple sclerosis -Study 2 Genome-wide association studies suggest a connection between genes encoding IL-7R and IL-7 to MS 17 . This study was conducted to elucidate the role of IL-7 and IL-7R genes in the pathogenesis and progression of MS by determining gene expression in experimental autoimmune encephalomyelitis (EAE) C57BL/6J mice and Lewis rats. Genetic linkage, candidate gene association, and gene expression studies have been conducted to identify genes linked to MS. Two genes suggested to be associated with MS with some consistency are the interleukin-7 (IL-7) gene and interleukin-7 receptor (IL-7R) gene. IL-7, a key pleiotropic cytokine, stimulates differentiation and proliferation required for normal B and T cell development 44 . IL-7 is known to exert growth promoting and antiapoptotic effects on T-cells and has been shown to enhance the T-cell mediated response to myelin proteins 45, 46 . Additionally, IL-7 may have a role in the inflammatory response by continually activating T-cells to secrete proinflammatorycytokines 47 . 30 female C57BL/6J mice separated into 3 equal groups (A, B, and C). The mice were subcutaneously injected with MOG 48 peptideemulsified in Complete Freund's adjuvant (CFA). All mice were sacrificed 50 days after induction of EAE. Blood samples were obtained. Brain and spinal cord tissue was stored at -80°C. Group A was the control group for acute and chronic relapsing stages of EAE. Group B received intraperitoneal injections of thymoquinone for 50 days following EAE induction. Group C received intraperitoneal injections of thymoquinone after the first appearance of chronic symptoms. Lewis Rat brain and spinal cord frozen at -80°C was obtained for genetic analysis. Group A was induced with EAE but had no anti-oxidant treatment. Group B was induced with EAE and had anti-oxidant treatment of BHA. The genetic control was not induced with EAE and had no anti-oxidant treatment. A significant increase of glutathione was observed in mice with reduced symptoms, likely due to TQ anti-oxidant activity. Gene expression studies remain elusive but point towards the involvement of IL-7R in the progression and pathogenesis of EAE.
CONCLUSION:
It is well known that animal models are extensively used in research filed. In recent years, transgenic mouse models have become crucial tools in human disease research. The application of transgenic animals continuously proves to be one of the most valuable techniques in understanding disease mechanisms; they provide comparable subjects to distinguish the effects of genetic and environmental factors on pathogenesis, understanding the role of complex interactions of molecular and cellular processes and mechanisms on the disease progression 18 . Scientists have developed numerous methods relating to the transgenic animal models; in addition, they established more emphasis in minimizing animal suffering while achieving the utmost benefits to medicine 19 .
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